- Home
- PMEC vs CRIS Comparison
PMEC vs CRIS Comparison
Compare PMEC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- CRIS
- Stock Information
- Founded
- PMEC 1984
- CRIS 2000
- Country
- PMEC Singapore
- CRIS United States
- Employees
- PMEC N/A
- CRIS N/A
- Industry
- PMEC
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMEC
- CRIS Health Care
- Exchange
- PMEC Nasdaq
- CRIS Nasdaq
- Market Cap
- PMEC 28.6M
- CRIS 32.8M
- IPO Year
- PMEC 2023
- CRIS 2000
- Fundamental
- Price
- PMEC $0.74
- CRIS $3.29
- Analyst Decision
- PMEC
- CRIS Strong Buy
- Analyst Count
- PMEC 0
- CRIS 3
- Target Price
- PMEC N/A
- CRIS $23.00
- AVG Volume (30 Days)
- PMEC 1.4M
- CRIS 243.3K
- Earning Date
- PMEC 12-31-2024
- CRIS 02-06-2025
- Dividend Yield
- PMEC N/A
- CRIS N/A
- EPS Growth
- PMEC N/A
- CRIS N/A
- EPS
- PMEC N/A
- CRIS N/A
- Revenue
- PMEC $72,524,000.00
- CRIS $10,259,000.00
- Revenue This Year
- PMEC N/A
- CRIS N/A
- Revenue Next Year
- PMEC N/A
- CRIS N/A
- P/E Ratio
- PMEC N/A
- CRIS N/A
- Revenue Growth
- PMEC 5.07
- CRIS 0.44
- 52 Week Low
- PMEC $0.49
- CRIS $2.86
- 52 Week High
- PMEC $4.15
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- PMEC 51.64
- CRIS 44.97
- Support Level
- PMEC $0.56
- CRIS $3.10
- Resistance Level
- PMEC $1.13
- CRIS $3.60
- Average True Range (ATR)
- PMEC 0.13
- CRIS 0.37
- MACD
- PMEC 0.00
- CRIS 0.00
- Stochastic Oscillator
- PMEC 34.36
- CRIS 26.22
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.